Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r9data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

SecureCell AG

History from 18 Aug 2017

UID
CHE-114.900.241
Legal form
AG
Canton
ZH
Founded
not in the record
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 401k
100k200k301k401k13 Dec 2018 · CHF 290k1 Nov 2019 · CHF 294k24 Mar 2020 · CHF 308k21 Dec 2020 · CHF 323k13 Apr 2021 · CHF 326k14 Dec 2021 · CHF 335k13 Dec 2022 · CHF 348k28 Apr 2023 · CHF 350k18 Dec 2024 · CHF 361k24 Dec 2025 · CHF 366k8 Oct 2026 · CHF 401k20192020202120222023202420252026
  • shares

Record

  1. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    265’000 → 290’000
    Shares
    2’650’000 → 2’900’000
    New shares, % of post-step shares
    8.6% (250’000 new)
    SHAB HR02-1004519579 ↗
  2. Capital increase

    Not assessed

    Paid by converting claims

    Nominal capital
    290’000 → 294’000
    Shares
    2’900’000 → 2’940’000
    New shares, % of post-step shares
    1.4% (40’000 new)
    SHAB HR02-1004750011 ↗
  3. Capital increase

    Not assessed

    Issued from conditional capital

    Nominal capital
    294’000 → 308’155
    Shares
    2’940’000 → 3’081’550
    New shares, % of post-step shares
    4.6% (141’550 new)
    SHAB HR02-1004858726 ↗
  4. Capital increase

    Not assessed

    Paid by converting claims

    Nominal capital
    308’155 → 322’655
    Shares
    3’081’550 → 3’226’550
    New shares, % of post-step shares
    4.5% (145’000 new)
    SHAB HR02-1005052946 ↗
  5. Capital increase

    Not assessed

    Issued from conditional capital

    Nominal capital
    322’655 → 326’070
    Shares
    3’226’550 → 3’260’700
    New shares, % of post-step shares
    1.0% (34’150 new)
    SHAB HR02-1005147380 ↗
  6. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    326’070 → 334’570
    Shares
    3’260’700 → 3’345’700
    New shares, % of post-step shares
    2.5% (85’000 new)
    SHAB HR02-1005356154 ↗
  7. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    334’570 → 347’718
    Shares
    3’345’700 → 3’477’180
    New shares, % of post-step shares
    3.8% (131’480 new)
    SHAB HR02-1005626749 ↗
  8. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    347’718 → 349’818
    Shares
    3’477’180 → 3’498’180
    New shares, % of post-step shares
    0.6% (21’000 new)
    SHAB HR02-1005734200 ↗
  9. Capital band adopted

    SHAB HR02-1005756521 ↗
  10. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    349’818 → 361’442.50
    Shares
    3’498’180 → 3’614’425
    New shares, % of post-step shares
    3.2% (116’245 new)
    SHAB HR02-1006208153 ↗
  11. Capital increase

    Capital increased · undecided

    Paid in cash and by other means

    Nominal capital
    361’442.50 → 365’982.50
    Shares
    3’614’425 → 3’659’825
    New shares, % of post-step shares
    1.2% (45’400 new)
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5
    • A small increment typical of employee share options.−1.0

    Classifier score 0.35 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006523629 ↗
  12. Capital increase

    Likely financing

    Paid in cash and by other means

    Nominal capital
    365’982.50 → 400’982.50
    Shares
    3’659’825 → 4’009’825
    New shares, % of post-step shares
    8.7% (350’000 new)
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.62 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006777396 ↗

Published by 8 Oct 2026